“…Similar to humans, animals will readily self‐administer most drugs of abuse (for reviews, see Schuster and Thompson, 1969 ; Spealman and Goldberg, 1978 ; Balster and Lukas, 1985 ; Young and Herling, 1986 ), including opiates ( Weeks, 1962 ; Blakesley et al ., 1972 ), cannabinoids ( Takahashi and Singer, 1979 ; Justinova et al ., 2003 ), alcohol ( Woods et al ., 1971 ; Anderson and Thompson, 1974 ), nicotine ( Hanson et al ., 1979 ; Ator and Griffiths, 1983 ), amphetamines ( Pickens et al ., 1967 ; Pickens and Harris, 1968 ; Balster et al ., 1976 ) and cocaine ( Pickens and Thompson, 1968 ; Goldberg and Kelleher, 1976 ), with studies almost universally demonstrating that animals will preferentially respond on a reinforced (that is, active), rather than a non‐reinforced (that is, inactive) operandum. Although a variety of species and routes of drug administration can be used, most studies involve the use of rodents ( Weeks, 1972 ; Smith and Davis, 1975 ) or non‐human primates ( Deneau et al ., 1969 ; Stretch and Gerber, 1970 ) self‐administering drugs orally ( Anderson and Thompson, 1974 ; Yanaura et al ., 1980 ), intracranially ( Bozarth and Wise, 1981 ; Phillips et al ., 1981 ) or intravenously via a chronic indwelling catheter ( Griffiths et al ., 1978 ; Spealman and Goldberg, 1978 ). The abuse potential of a drug in humans can be predicted from animal intravenous self‐administration models ( Collins et al ., 1984 ), which clearly models the clinical abuse of drugs far better than repeated experimenter‐delivered drug via intraperitoneal or subcutaneous administration ( Markou et al ., 1993 ).…”